Zenivate MF Ointment is a topical formulation combining Clobetasol propionate (0.05% w/w), Salicylic Acid (3% w/w), Lactic Acid (10% w/w), and Urea (3% w/w), designed for the effective management of various hyperkeratotic and inflammatory dermatoses. Clobetasol propionate, a potent corticosteroid, provides strong anti-inflammatory, antipruritic, and vasoconstrictive effects, reducing erythema, swelling, and itching associated with skin disorders. Salicylic Acid acts as a keratolytic agent, facilitating the exfoliation of hyperkeratotic skin and enhancing the penetration of other active ingredients. Lactic Acid, an alpha-hydroxy acid, contributes to gentle exfoliation, moisturization, and restoration of the skin’s natural pH, promoting smoother and softer skin texture. Urea serves as a humectant and keratolytic, improving skin hydration and aiding in the breakdown of thickened skin. The synergistic action of these components makes Zenivate MF Ointment suitable for conditions such as psoriasis, eczema, lichen planus, and other hyperkeratotic inflammatory dermatoses. It should be used under medical supervision, adhering to recommended dosage and duration to minimize potential side effects associated with corticosteroid use. Avoid application on infected or sensitive areas unless directed by a healthcare professional.